// App-Quantinova.ai

P1426 : WU-NK-101, AN ALLOGENEIC MEMORY NK CELL, FOR THE TREATMENT OF RELAPSE OR REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)

Researchers

Presenter

  • John J Muth

Principal Investigators

  • Lena Luukkonen

  • Mark Foster

  • Julian Gorrochategui

  • Paula Comune Pennacchi

  • Daniel Primo

  • Juan Ballesteros

  • Vladimir Tolstikov

  • Michael A. Kiebish

  • Punit Shah

  • Jayakumar Vadakekolathu

  • Sergio Rutella

  • Todd A Fehniger

  • Ryan Sullivan

  • Ayman Kabakibi

  • Matthew L Cooper

  • Jan Davidson-Moncada

Medical Centers

  • Nottingham Trent University,Nottingham,Regno Unito

  • Wugen,St Louis,Verenigde Staten

  • Wugen,San Diego,Estados Unidos

  • Berg Health,Framingham,Verenigde Staten

  • Wugen,St Louis,Stati Uniti

  • Wugen,St Louis,Estados Unidos

  • Washington University St Louis,St Louis,Vereinigtes Königreich

  • Vivia Biotech,Madrid,Espanha

  • Wugen,San Diego,USA

  • Berg Health,Framingham,USA

  • Nottingham Trent University,Nottingham,Verenigd Koninkrijk

  • Washington University,St. Louis, MO,Verenigde Staten

  • Vivia Biotech, Madrid, Spain

  • Washington University St Louis,St Louis,Stati Uniti

  • Vivia Biotech, Madrid, Spain

  • Berg Health,Framingham,Estados Unidos

  • Berg Health,Framingham,Stati Uniti

  • Washington Univer

  • Washington University St Louis,St Louis,Vereinigtes Königreich

  • Washington University St Louis,St Louis,Stati Uniti

  • Nottingham Trent University, Nottingham, United Kingdom

  • Washington University St Louis,St Louis,Vereinigtes Königreich

  • Wugen,San Diego,Verenigde Staten

  • Wugen,St Louis,USA

  • Washington University St Louis,St Louis,Stati Uniti

  • Vivia Biotech, Madrid, Spain

  • Vivia Biotech,Madrid,Испания

  • Nottingham Trent Univ

  • Wugen,St Louis,Verenigde Staten

  • Washington University St Louis,St Louis,Stati Uniti

  • Washington University, St. Louis, Missouri, United States

  • Vivia Biotech,Madrid,Espanha

  • Wugen,San Diego,Stati Uniti

  • Berg Health,Framingham,United States

  • Washington University St Louis,St Louis,Stati Uniti

  • Wugen,St Louis,United States

  • Wugen,San Diego,Verenigde Staten

  • Wugen,San Diego,États-unis

  • Nottingham Trent University,Nottingham,Royaume-uni

  • Berg Health,Framingham,Verenigde Staten

  • Washington University St Louis,St Louis,Stati Uniti

  • Wugen,St Louis,États-unis

  • Wugen,San Diego,United States

  • Washington University St Louis,St Louis,United Kingdom

  • Vivia Biotech,Madrid,Espanha

  • Nottingham Trent University,Nottingham,Regno Unito

  • Berg Health,Framingham,États-unis

  • Washington Univer

  • Nottingham Trent University,Nottingham,Verenigd Koninkrijk

  • Vivia Biotech, Madrid, Spain

Locations

  • United States

  • United Kingdom

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • NCT01898793

Sponsors

  • N/A

Result

  • N/A